{"aaData": [["1", "SMALL INTESTINE", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["10", "STOMACH", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["11", "COLON & RECTUM", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["12", "ANAL CANAL", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["13", "LIVER", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["14", "GALLBLADDER", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "", ""], ["15", "EXTRAHEPATIC BILE DUCTS", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "", ""], ["16", "AMPULLA OF VATER", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["17", "EXOCRINE PANCREAS", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["18", "LUNG", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["19", "BONE", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["2", "PLEURAL MESOTHELIOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["20", "SOFT TISSUES", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["21", "SKIN CARCINOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["22", "SKIN MELANOMA", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT1b Melanoma < or = 1.0 mm in thickness and level IV or\n      V or with ulceration\nT2  Melanoma 1.01 - 2 mm in thickness with or without ulceration\nT2a Melanoma 1.01 - 2 mm in thickness, no ulceration\nT2b Melanoma 1.01 - 2 mm in thickness, with ulceration\nT3  Melanoma 2.01 - 4 mm in thickness with or without ulceration\nT3a Melanoma 2.01 - 4 mm in thickness, no ulceration\nT3b Melanoma 2.01 - 4 mm in thickness, with ulceration\nT4  Melanoma greater than 4.0 mm in thickness with\n      or without ulceration\n\nT4a Melanoma greater than 4.0 mm in thickness, no ulceration\nT4b Melanoma greater than 4.0 mm in thickness, with ulceration\nTX  Primary tumor cannot be assessed (e.g. shave\n      biopsy or regressed melanoma)\nT0  No evidence of primary tumor\nTis Melanoma 'in situ'\nT1  Melanoma < or = 1.0 mm in thickness with or without ulceration\nT1a Melanoma < or = 1.0 mm in thickness and level II or\n      III, no ulceration\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\nN2a Clinically occult (microscopic) metastasis\nN2b Clinically apparent (macroscopic) metastasis\nN2c Satellite or in-transit metastasis without nodal\n      metastasis\nN3  Metastasis in four or more regional modes, or matted\n      metastatic nodes, or in-transit metastasis or\n      satellite(s) with metastasis in regional node(s)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Metastasis in one lymph node\nN1a Clinically occult (microscopic) metastasis\nN1b Clinically apparent (macroscopic) metastasis\nN2  Metastasis in 2 or 3 regional nodes or intralymphatic\n      regional metastasis without nodal metastases\n
\n
\n", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n      metastasis at any site associated with an elevated\n      serum lactic dehydrogenase (LDH) \n\nMX  Distant metastasis cannot be assessed\nM0  No distant metastasis\nM1  Distant metastasis\nM1a Metastasis to skin, subcutaneous tissues\n       or distant lymph nodes\nM1b Metastasis to lung\nM1c Metastasis to all other visceral sites or distant\n
\n
\n", "", "", "", "", "
\n
\n\n
\n", "", "", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor (T)\n      invades to papillary-reticular dermal interface (Clark's Level III)\nT3  Tumor more than 1.5 mm but not more than 4 mm in thickness and/or\n      invades the reticular dermis (Clark's Level IV)\nT3a Tumor more than 1.5 mm but not more than 3 mm in thickness\nT3b Tumor more than 3 mm but not more than 4 mm in thickness\nT4  Tumor more than 4 mm in thickness and/or invades the subcutaneous tissue\n      (Clark's Level V) and/or satellite(s) within 2 cm of the primary tumor\nT4a Tumor more than 4 mm in thickness and/or invades the subcutaneous tissue\nT4b Satellite(s) within 2 cm of the primary tumor\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nTis Melanoma 'in situ' (atypical melanocytic hyperplasia, severe melanocytic\n      dysplasia), not an invasive malignant lesion (Clark's Level I)\nT1  Tumor 0.75 mm or less in thickness and invades the papillary dermis\n      (Clark's Level II)\nT2  Tumor more than 0.75 mm but not more than 1.5 mm in thickness and/or\n
\n
\n", "
\nRegional Lymph Nodes (N)\nN2a Metastasis more than 3 cm in greatest dimension\n      in any regional lymph node(s)\nN2b In-transit metastasis\nN2c Both (N2a and N2b)\n\nNote: In-transit metastasis involves skin or \nsubcutaneous tissue more than 2 cm from the\nprimary tumor but not beyond the regional lymph\nnodes.\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Metastasis 3 cm or less in greastest dimension\n      in any regional lymph node(s)\nN2  Metastasis more than 3 cm in greatest dimension\n      in any regional lymph node(s) and/or in-transit\n      metastasis\n
\n
\n", "
\nDistant Metastasis (M)\n\nMX  Distant metastasis cannot be assessed\nM0  No distant metastasis\nM1  Distant metastasis\nM1a Metastasis in skin or subcutaneous\n      tissue or lymph node(s) beyond the\n      regional lymph nodes\nM1b Visceral metastasis\n
\n
\n"], ["23", "BREAST", "", "", "", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N) Pathologic\nN0(mol-) No regional lymph node metastasis histologically, negative\n           molecular findings (RT-PCR)\nN0(mol+) No regional lymph node metastasis histologically, positive\n           molecular findings (RT-PCR)\nN1       Metastasis in 1 to 3 axillary lymph nodes, and/or in internal\n           mammary nodes with microscopic disease detected by sentinel\n           lymph node dissection but not clinically apparent \nN1mi     Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm)   \nN1a      Metastasis in 1 to 3 axillary lymph nodes\nN1b      Metastasis in internal mammary nodes with microscopic disease\n\n           detected by sentinel lymph node dissection but not clinically\n           apparent\nN1c      Metastasis in 1 to 3 axillary lymph nodes and in internal mammary\n           lymph nodes with microscopic disease detected by sentinel lymph\n           node dissection but not clinically apparent\nN2       Metastasis in 4 to 9 axillary lymph nodes, or in clinically\n           apparent internal mammary lymph nodes in the absence of axillary\n           lymph node metastasis\nN2a      Metastasis in 4 to 9 axillary lymph nodes (at least one tumor\n           deposit greater than 2.0 mm)\nNX       Regional lymph nodes cannot be assessed (eg, previously removed,\nN2b      Metastasis in clinically apparent internal mammary lymph nodes in\n           the absence of axillary lymph node metastasis\nN3       Metastasis in 10 or more axillary lymph nodes, or in infraclavicular\n           lymph nodes, or in clinically apparent ipsilateral internal mammary\n           lymph nodes in the presence of 1 or more positive axillary lymph\n           nodes; or in more than 3 axillary lymph nodes with clinically\n           negative microscopic metastasis in internal mammary lymph nodes; or\n           in ipsilateral supraclavicular lymph nodes\nN3a      Metastasis in 10 or more axillary lymph nodes (at least one tumor\n           deposit greater than 2.0 mm), or metastasis to the infraclavicular\n           or not removed for pathologic study)\n           lymph nodes\nN3b      Metastasis in clinically apparent ipsilateral internal mammary lymph\n           nodes in the presence of 1 or more positive axillary lymph nodes;\n           or in more than 3 axillary  lymph nodes and in internal mammary\n           lymph nodes with microscopic disease detected by sentiel lymph\n           node dissection but not clinically apparent\nN3c      Metastasis in ipsilateral supraclavicular lymph nodes\nN0       No regional lymph node metastasis histologically, no additional\n           examination for isolated tumor cells (ITC)\nN0(i-)   No regional lymph node metastasis histologically, negative IHC\nN0(i+)   No regional lymph node metastasis histologically, positive IHC,\n           no IHC cluster greater than 0.2 mm\n
\n
\n", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "
\nRegional Lymph Nodes (N)\n             and all less than 2 cm in greatest dimension\n    N1bii  Metastasis to 4 or more lymph nodes, any more than 0.2 cm\n             and all less than 2 cm in greatest dimension\n    N1biii Extension of tumor beyond the capsule of a lymph node\n             metastasis less than 2 cm in greatest dimension\n    N1biv  Metastasis to a lymph node 2 cm or more in greatest dimension\nN2  Metastasis to ipsilateral axillary lymph nodes that are fixed to one\n      another or to other structures\nN3  Metastasis to ipsilateral internal mammary lymph node(s)\n\nNX  Regional lymph nodes cannot be assessed (e.g., previously\n      removed, or not removed for pathologic study)\nN0  No regional lymph node metastasis\nN1  Metastasis to movable ipsilateral axillary lymph node(s)\n    N1a    Only micrometastasis (none larger than 0.2 cm)\n    N1b    Metastasis to lymph node(s), any larger than 0.2 cm\n    N1bi   Metastasis is 1 to 3 lymph nodes, any more than 0.2 cm\n
\n
\n", ""], ["24", "CERVIX UTERI", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["25", "CORPUS UTERI", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT2b  Tumor involves other pelvic tissues\nT3   Tumor infiltrates abdominal tissues\nT3a  One site\nT3b  More than one site\nT4   Tumor invades bladder or rectum\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor limited to the uterus\nT1a  Tumor 5 cm or less in greatest dimension\nT1b  Tumor more than 5 cm\nT2   Tumor extends beyond the uterus, within the pelvis\nT2a  Tumor involves adnexa\n
\n
\n", "", "", "
\n
\n\n
\n", "", "", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor (T)\nT1c  IC   Tumor invades to more than one-half of the myometrium\nT2   II   Tumor invades cervix but does not extend beyond uterus\nT2a  IIA  Endocervical glandular involvement only\nT2b  IIB  Cervical stromal invasion\nT3   III  Local and/or regional spread as specified in T3a, b, and/or N1 and\n            FIGO IIIA, B, and C below\nT3a  IIIA Tumor involves serosa and/or adnexa (direct extension or meta-\n            stasis) and/or cancer cells in ascites or peritoneal washings\nT3b  IIIB Vaginal involvement (direct extension or metastasis)\nT4   IVA  Tumor invades bladder mucosa and/or bowel mucosa\n\nTNM FIGO\nTX        Primary tumor cannot be assessed\nT0        No evidence of primary tumor\nTis       Carcinoma 'in situ'\nT1   I    Tumor confined to corpus uteri\nT1a  IA   Tumor limited to endometrium\nT1b  IB   Tumor invades up to or less than one-half of the myometrium\n
\n
\n", "
\nRegional Lymph Nodes (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "
\nDistant Metastasis (M)\n\nMX......Distant metastasis cannot be assessed\nM0......No distant metastasis\nM1......Distant metastasis\n
\n
\n"], ["26", "OVARY", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["27", "VAGINA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["28", "VULVA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\n
\n\n
\n", "", "", ""], ["29", "PROSTATE", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor, Pathologic (T)\nT3   Extraprostatic extension\nT3a  Extraprostatic extension or microscopic\n       invasion of bladder neck\nT3b  Seminal vesicle extension\nT4   Invasion of rectum, levator muscles, and/or\n       pelvic wall\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT2   Organ confined\nT2a  Unilateral, one-half of one side or less\nT2b  Unilateral, involving more than one-half of\n       side but not both sides\nT2c  Bilateral disease\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes, Pathologic (N)\n\nNX  Regional nodes not sampled   \nN0  No positive regional nodes   \nN1  Metastases in regional node(s)   \n
\n
\n", "", "
\nDistant Metastasis (M)\n\nMX   Distant metastasis cannot be assessed\n       (not evaluated by any modality)\nM0   No distant metastasis\nM1   Distant metastasis\nM1a  Non-regional lymph node(s)\nM1b  Bone(s)\nM1c  Other site(s) with or without bone disease\n
\n
\n", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor, Pathologic (T)\nT4   Invasion of bladder, rectum\n\nNote: There is no pathologic T1 classification.\n\nTX   Primary tumor cannot be assessed\nT2   Organ confined\nT2a  Unilateral\nT2b  Bilateral\nT3   Extraprostatic extension\nT3a  Extraprostatic extension\nT3b  Seminal vesicle extension\n
\n
\n", "
\nRegional Lymph Nodes, Pathologic (N)\n\nNX  Regional nodes cannot be not assessed   \nN0  No regional lymph node metastasis   \nN1  Metastases in regional lymph node or nodes   \n
\n
\n", "
\nDistant Metastasis (M)\n\nMX   Distant metastasis cannot be assessed\nM0   No distant metastasis\nM1   Distant metastasis\nM1a  Nonregional lymph node(s)\nM1b  Bone(s)\nM1c  Other site(s)\n
\n
\n"], ["3", "LIP AND ORAL CAVITY", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", ""], ["30", "TESTIS", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "
\nRegional Lymph Nodes (N)\n      cm but not more than 5 cm in greatest dimension;\n      or more than 5 nodes positive, none more than 5 cm;\n      or evidence of extranodal extension of tumor\nN3  Metastasis with a lymph node mass more than 5\n      cm in greatest dimension\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Metastasis with a lymph node mass, 2 cm or less\n      in greatest dimension and less than or equal\n      to 5 nodes positive, none more than 2 cm in\n      greatest dimension\nN2  Metastasis with a lymph node mass, more than 2\n
\n
\n", ""], ["31", "PENIS", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nRegional Lymph Nodes\n \nNX  Regional lymph nodes cannot be assessed\nN0  No palpable or visibly enlarged inguinal lymph nodes\nN1  Palpable mobile unilateral inguinal lymph node\nN2  Palpable mobile multiple or bilateral inguinal lymph nodes\nN3  Palpable fixed inguinal nodal mass or pelvic lymphadenopathy\n     unilateral or bilateral\n
\n
\n", "", "", "", "", "", "", "", "", ""], ["32", "URINARY BLADDER", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["33", "KIDNEY", "
\n
\n\n
\n", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["34", "RENAL PELVIS & URETER", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["35", "URETHRA", "
\n
\n\n
\n", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "
\nUrothelial (Transitional Cell) Carcinoma of the Prostate\n         prostatic stroma, corpus spongiosum,\n         periurethral muscle\nT3     Tumor invades any of the following:\n         corpus cavernosum, beyond prostatic capsule, \n         bladder neck (extraprostatic extension)\nT4     Tumor invades other adjacent organs\n         (invasion of the bladder)\n     \nTis pu Carcinoma 'in situ', involvement of\n         the prostatic urethra\nTis pd Carcinoma 'in situ', involvement of\n         the prostatic ducts\nT1     Tumor invades subepithelial connective\n         tissue\nT2     Tumor invades any of the following:\n
\n
\n", "", ""], ["36", "EYELID CARCINOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["37", "EYELID MELANOMA", "
\n
\n\n
\n", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "", ""], ["38", "CONJUNCTIVA CARCINOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["39", "CONJUNCTIVA MELANOMA", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT4  Tumor invades the eyelid, globe, orbit, sinuses,\n      or central nervous system\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor of the bulbar conjunctiva\nT2  Tumor of bulbar conjunctiva with corneal\n      extension\nT3  Tumor extending into the conjunctival fornix,\n      palpebral conjuntiva, or caruncle\n
\n
\n", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT1c  More than 2 but less than or equal to 3 quadrants\nT1d  Greater than 3 quadrants\n \nMalignant conjunctival melanoma of the non-bulbar (palpebral, forniceal\ncaruncular)\nT2a  Non-caruncular, less than or equal to 1 quadrant\nT2b  Non-caruncular, greater than 1 quadrant\nT2c  Any caruncular, less than or equal to 1 quadrant\nT2d  Any caruncular, greater than 1 quadrant\n \n \nAny malignant conjunctival melanoma with local invasion\nT3a  Globe\nT3b  Eyelid\nT3c  Orbit\nT3d  Sinus\nT4   Tumor invades the central nervous system\nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nTis  Melanoma confined to the conjunctival epithelium\n \nMalignant conjunctival melanoma of the bulbar conjunctiva\nT1a  Less than or equal to 1 quadrant\nT1b  More than 1 but less than or equal to 2 quadrants\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX   Regional lymph nodes cannot be assessed\nN0a  No regional lymph node metastasis, biopsy performed\nN0B  No regional lymph node metastasis, biopsy not performed\nN1   Regional lymph node metastasis\n
\n
\n", "
\n
\n\n
\n", "", "", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor (T)\n      palpebral conjuntiva and/or caruncle\nT4  Tumor invades eyelid, cornea, and/or\n      orbit\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor(s) of bulbar conjunctiva occupying\n      one quadrant or less\nT2  Tumor(s) of bulbar conjunctiva occupying\n      more than one quadrant\nT3  Tumor(s) of conjunctival fornix and/or\n
\n
\n", "
\nRegional Lymph Nodes (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", ""], ["4", "PHARYNX", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["40", "UVEA MELANOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["41", "RETINOBLASTOMA (PATH)", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor Pathologic (T)\nT2b  Tumor invades choroid focally\nT2c  Tumor invades optic nerve up to, but not through,\n       the level of the lamina cribrosa and invades the choroid focally\nT3   Significant invasion of the optic nerve and/or optic coats\nT3a  Tumor invades optic nerve through the level of the lamina cribrosa\n       but not to the line of resection\nT3b  Tumor massively invades the choroid\nT3c  Tumor invades the optic nerve through the level of the lamina cribrosa\n       but not to the line of resection and massively invades the choroid\nT4   Extraocular tumor extension\n\nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor confined to the retina,vitreous, or subretinal space.\n       No optic nerve or choroidal invasion.\nT2   Minimal invasion of the optic nerve and/or optic coats\nT2a  Tumor invades optic nerve up to, but not through, the level\n       of the lamina cribrosa\n
\n
\n", "", "", "
\n
\n\n
\n", "
\nDistant Metastasis Pathologic (M)\n\nMX   Distant metastasis cannot be assessed   \nM0   No distant metastasis   \nM1   Distant metastasis   \nM1a  Bone marrow   \nM1b  Other sites   \n
\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n      lamina cribrosa and exhibits focal choroidal invasion\nT3   Tumor with significant optic nerve and/or choroidal invasion\nT3a  Tumor invades optic nerve past lamina cribrosa but not to surgical \n      resection line or tumor exhibits massive choroidal invasion\nT3b  Tumor invades optic nerve past lamina cribrosa but not to surgical \n      resection line and exhibits massive choroidal invasion\nT4   Tumor invades optic nerve to resection line or exhibits extraocular \n      extension elsewhere\nT4a  Tumor invades optic nerve to resection line but no extraocular\n      extension identified\n \nT4b  Tumor invades optic nerve to resection line and extraocular extension\n      identified\nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor confined to eye with no optic nerve or choroidal invasion\nT2   Tumor with minimal optic nerve and/or choroidal invasion\nT2a  Tumor superficially invades optic nerve head but does not extend past\n      lamina cribrosa or tumor exhibits focal choroidal invasion\nT2b  Tumor superficially invades optic nerve head but does not extend past\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node involvement\nN1  Regional lymph node involvement (preauricular, cervical)\nN2  Distant lymph node involvement\n
\n
\n", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM1   Metastasis to sites other than CNS\nM1a  Single lesion\nM1b  Multiple lesions\nM1c  CNS metastasis\nM1d  Discrete mass(es) without leptomeningeal and/or CSF involvement\nM1e  Leptomeningeal and/or CSF involvement\n
\n
\n", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor Pathologic (T)\nT3a Tumor(s) involve(s) more than 50% of the retina\n      and/or tumor cells in the vitreous\nT3b Tumor(s) involve(s) optic nerve\n      as far as the lamina cribosa\nT3c Tumor(s) in anterior chamber and/or invasion with\n      thickening of the uvea and/or intrascleral invasion\nT4  Tumor with extra-ocular invasion\nT4a Intraneural tumor beyond the lamina cribosa\n      but not at the line of resection\nT4b Tumor at the line of resection or\n\n      other extra-ocular extension\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor(s) limited to 25% or less of the retina\nT2  Tumor(s) involve(s) more than 25% but not more\n      than 50% of the retina\nT3  Tumor(s) involve(s) more than 50% of the retina and/or\n      invade(s) beyond the retina but remain(s) intra-ocular\n
\n
\n", "
\nRegional Lymph Nodes Pathologic (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", ""], ["42", "ORBIT SARCOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["43", "LACRIMAL GLAND CARCINOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["44", "BRAIN", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["45", "HODGKIN'S DISEASE", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", ""], ["46", "NON-HODGKIN'S LYMPHOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", ""], ["47", "NEPHROBLASTOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["48", "NEUROBLASTOMA", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["49", "SOFT-TISSUE SARCOMA-PED", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["5", "LARYNX", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["50", "CONJUNCTIVA MELANOMA (PATH)", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor, Pathologic (T)\nT3  Tumor of the bulbar conjunctiva more than 0.8 mm\n      in thickness with invasion of the substantia\n      propria or tumors involving the palpebral or\n      caruncular conjunctiva\nT4  Tumor invades the eyelid, globe, orbit, sinuses,\n      or central nervous system\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor of the bulbar conjunctiva confined to the\n      epethelium\nT2  Tumor of the bulbar conjunctiva not more than\n      0.8 mm in thickness with invasion of the substantia\n      propria\n
\n
\n", "", "
\nRegional Lymph Nodes (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT1c  Melanoma of the bulbar conjunctiva greater than 1.5 mm in thickness\n      with invasion of the substantia propria\nT2a  Melanoma of the palpebral, forniceal or caruncular conjunctiva not\n      more than 0.5 mm in thickness with invasion of the substantia\n      propria\nT2b  Melanoma more than 0.5 but not greater than 1.5 mm in thickness with \n      invasion of the substantia propria\nT2c  Melanoma of the palpebral, forniceal or caruncular conjunctiva\n      greater than 1.5 mm in thickness with invasion of the substantia\n      propria\n \nT3   Melanoma invades the eye, eyelid, nasolacrimal system, sinuses or\n      orbit\nT4   Melanoma invades the central nervous system\nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nTis  Melanoma confined to the conjunctival epithelium\nT1a  Melanoma of the bulbar conjunctiva not more than 0.5 mm in thickness\n      with invasion of the substantia propria\nT1b  Melanoma of the bulbar conjunctiva more than 0.5 mm but not more than\n      1.5 mm in thickness with invasion of the substantia propria\n
\n
\n", "", "", "
\n
\n\n
\n", "", "", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor, Pathologic (T)\n      palpebral conjunctiva and/or caruncle or tumor(s)\n      of the bulbar conjucntiva, more than 2 mm in thickness\nT4  Tumor invades eyelid, cornea, and/or orbit\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor(s) of the bulbar conjunctiva occupying\n      one quadrant or less and 2 mm or less in thickness\nT2  Tumor(s) of the bulbar conjunctiva occupying\n      more than one quadrant and 2 mm  or less in thickness\nT3  Tumor(s) of the conjunctival fornix and/or\n
\n
\n", "", ""], ["51", "CILIARY BODY", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT1b  Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest\n       height (thickness) with microscopic extraocular extension\nT1c  Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest\n       height (thickness) with macroscopic extraocular extension\nT2   Tumor greater than 10 mm but not more than 16 mm in greatest basal\n       diameter and between 2.5 and 10 mm in maximum height (thickness)\nT2a  Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm\n       in maximum height (thickness) without microscopic extraocular extension\nT2b  Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm\n       in maximum height (thickness) with microscopic extraocular extension\nCiliary Body\nT2c  Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm\n       in maximum height (thickness) with macroscopic extraocular extension\nT3   Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in\n       maximum height (thickness) without extraocular extension\nT4   Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in\n        maximum height (thickness) with extraocular extension\n\nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest\n       height (thickness)\nT1a  Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest\n        height (thickness) without microscopic extraocular extension\n
\n
\n", "", "
\nRegional Lymph Nodes (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional Lymph node metastasis\n
\n
\n", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n      extraocular extension less than or equal to 5 mm in diameter\nT1d  Tumor size category 1 with ciliary body involvement and extraocular\n      extension less than or equal to 5 mm in diameter\nT2   Tumor size category 2\nT2a  Tumor size category 2 without ciliary body involvement and\n      extraocular extension\nT2b  Tumor size category 2 with ciliary body involvement\nT2c  Tumor size category 2 without ciliary body involvement but with \n      extraocular extension less than or equal to 5 mm in diameter\nT2d  Tumor size category 2 with ciliary body involvement and extraocular\n \n      extension less than or equal to 5 mm in diameter\nT3   Tumor size category 3\nT3a  Tumor size category 3 without ciliary body involvement and\n      extraocular extension\nT3b  Tumor size category 3 with ciliary body involvement\nT3c  Tumor size category 3 without ciliary body involvement but with \n      extraocular extension less than or equal to 5 mm in diameter\nT3d  Tumor size category 3 with ciliary body involvement and extraocular\n      extension less than or equal to 5 mm in diameter\nT4   Tumor size category 4\nTX   Primary tumor cannot be assessed\nT4a  Tumor size category 4 without ciliary body involvement and\n      extraocular extension\nT4b  Tumor size category 4 with ciliary body involvement\nT4c  Tumor size category 4 without ciliary body involvement but with \n      extraocular extension less than or equal to 5 mm in diameter\nT4d  Tumor size category 4 with ciliary body involvement and extraocular\n      extension less than or equal to 5 mm in diameter\nT4e  Any tumor size category with extraocular extension more than 5 mm in\n     diameter\nT0   No evidence of primary tumor\nT1   Tumor size category 1\nT1a  Tumor size category 1 without ciliary body involvement and\n      extraocular extension\nT1b  Tumor size category 1 with ciliary body involvement\nT1c  Tumor size category 1 without ciliary body involvement but with \n
\n
\n", "", "", "
\n
\n\n
\n", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0   No distant metastasis\nM1   Distant metastasis\nM1a  Largest diameter of the largest metastasis <=3 cm\nM1b  Largest diameter of the largest metastasis 3.1-8.0 cm\nM1c  Largest diameter of the largest metastasis 8.1 cm or more\n
\n
\n", "", "
\n
\n\n
\n", "", "
\nPrimary Tumor (T)\n\nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor limited to ciliary body\nT2  Tumor invades into anterior chamber and/or iris\nT3  Tumor invades choroid\nT4  Tumor extraocular extension\n
\n
\n", "", ""], ["52", "VAGINA (LOWER 1/3)", "", "", "", "", "", "", "", "", "", "", "", "
\n
\n\n
\n", "", "", "", "", "", "", "", ""], ["53", "FALLOPIAN TUBE", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["54", "GESTATIONAL TROPHOBLASTIC", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["55", "MYCOSIS FUNGOIDES", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n\nTX  Primary tumor cannot be assessed\nT1  Limited patch/plaque   \nT2  Generalized patch/plaque   \nT3  Cutaneous tumors   \nT4  Generalized erythroderma   \n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n\nNX  Regional lymph nodes cannot be assessed\nN0  Lymph nodes clinically uninvolved   \nN1  Lymph nodes clinically enlarged, histologically uninvolved   \nN2  Lymph nodes clinically unenlarged, histologically involved   \nN3  Lymph nodes enlarged and histologically involved   \n
\n
\n", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n\nMX  Distant metastasis cannot be assessed\nM0  No visceral disease   \nM1  Visceral disease present   \n
\n
\n", "
\n
\n\n
\n", "
\nPrimary Tumor (T) Skin\nT4  Confluence of erythema covering 80% body surface area\n \nT1  Limited patches, papules, and/or plaques covering <10% of the skin surface\n    **per ISCL/EORTC: 'May further stratify into T1a (patch only) vs T1b\n    (plaque +/- patch)'. The T1a & T1b values are not part of the AJCC algorithm.\nT2  Patches, papules or plaques covering 10% of the skin surface.\n    **per ISCL/EORTC: 'May further stratify into T1a (patch only) vs T1b\n    (plaque +/- patch)'. The T2a & T2b values are not part of the AJCC algorithm.\nT3  One or more tumors (1-cm diameter)\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\nN2   Clinically abnormal peripheral lymph nodes; histopathology Dutch\n     grade 2 or NCI LN3\nN2a  Clone negative\nN2b  Clone positive\nN3   Clinically abnormal peripheral lymph nodes; histopathology Dutch\n     grades 3-4 or NCI LN4; clone positive or negative\n \nNX   Clinically abnormal peripheral lymph nodes; no histologic\n     confirmation\nN0   No clinically abnormal peripheral lymph nodes; biopsy not required\nN1   Clinically abnormal peripheral lymph nodes; histopathology Dutch\n     grade 1 or NCI LN0-2\nN1a  Clone negative\nN1b  Clone positive\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M) Visceral\n \nM0  No visceral organ involvement\nM1  Visceral involvement (must have pathology confirmation and organ \n    involved should be specified)\n
\n
\n", "", "", "", "", "", ""], ["56", "GASTROINTESTINAL STROMAL TUMOR", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n \nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor 2 cm or less\nT2  Tumor more than 2 cm but not more than 5 cm\nT3  Tumor more than 5 cm but not more than 10 cm\nT4  Tumor more than 10 cm in greatest dimension\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n \nIf regional node status is unknown, use N0, not NX.\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0   No distant metastasis\nM1   Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["57", "NEUROENDOCRINE STOMACH", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n     adjacent structures\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nTis  Carcinoma in situ/dysplasia (tumor size <0.5mm), confined to mucosa\nT1   Tumor invades lamina propria or submucosa and 1cm in size\nT2   Tumor invades muscularis propria or >1cm in size\nT3   Tumor penetrates subserosa\nT4   Tumor invades visceral peritoneum (serosa) or other organs or\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX   Regional lymph nodes cannot be assessed\nN0   No regional lymph node metastasis\nN1   Regional lymph node metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0   No distant metastasis\nM1   Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["58", "NEUROENDROCRINE DUO/AMP/JEJ/IL", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n     without penetration of overlying serosa (jejunal or ileal tumors) or\n     invades pancreas or retroperitoneum (ampullary or duodenal tumors )\n     or into nonperitonealized tissues.\nT4  Tumor invades visceral peritoneum (serosa) or invades other organs\n \nTX  Primary tumor cannot be assessed\nT0  No evidence of primary tumor\nT1  Tumor invades lamina propria or submucosa and size < or = 1 cm (small\n     intestinal tumors); tumor < or = 1 cm (ampullary tumors)\nT2  Tumor invades muscularis propria or size >1 cm (small intestinal\n     tumors); tumor >1 cm (ampullary tumors)\nT3  Tumor invades through the muscularis propria into subserosal tissue \n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0  No distant metastasis\nM1  Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["59", "NEUROENDOCRINE COLON OR RECTUM", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT3   Tumor invades through the muscularis propria into the subserosa, or\n      into non-peritonealized pericolic or perirectal tissues\nT4   Tumor invades peritoneum or other organs\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor invades lamina propria or submucosa and size < or = 2 cm\nT1a  Tumor size <1 cm in greatest dimension\nT1b  Tumor size 1 to 2 cm in greatest dimension\nT2   Tumor invades muscularis propria or size >2 cm with invasion of\n      lamina propria or submucosa\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0  No distant metastasis\nM1  Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["6", "PARANASAL SINUSES", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["60", "MERKEL CELL CARCINOMA", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nTis  In situ primary tumor\nT1   Less than or equal to 2 cm maximum tumor dimension\nT2   Greater than 2 cm but not more than 5 cm maximum tumor dimension\nT3   Over 5 cm maximum tumor dimension\nT4   Primary tumor invades bone, muscle, fascia, or cartilage\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX   Regional lymph nodes cannot be assessed\nN0   No regional lymph node metastasis\nN1   Metastasis in regional lymph node(s)\nN1a  Micrometastasis\nN1b  Macrometastasis\nN2   In transit metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0   No distant metastasis\nM1   Metastasis beyond regional lymph nodes\nM1a  Metastasis to skin, subcutaneous tissues or distant lymph nodes\nM1b  Metastasis to lung\nM1c  Metastasis to all other visceral sites\n
\n
\n", "", "", "", "", "", ""], ["61", "MUCOSAL MELANOMA OF HEAD/NECK", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n \nT3   Mucosal disease\nT4a  Moderately advanced disease\n     Tumor involving deep soft tissue, cartilage, bone, or overlying skin.\nT4b  Very advanced disease\n     Tumor involving brain, dura, skull base, lower cranial nerves (IX, X,\n      XI, XII), masticator space, carotid artery, prevertebral space, or\n      mediastinal structures\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis present\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis\n \nM0  No distant metastasis\nM1  Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["62", "APPENDIX", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT2   Tumor more than 2 cm but not more than 4 cm or with extension to the\n      cecum\nT3   Tumor more than 4 cm or with extension to the ileum\nT4   Tumor directly invades other adjacent organs or structures, e.g., \n      abdominal wall and skeletal muscle\n \nCarcinoid\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor 2 cm or less in greatest dimension\nT1a  Tumor 1 cm or less in greatest dimension\nT1b  Tumor more than 1 cm but not more than 2 cm\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nCarcinoid\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nCarcinoid\n \nM0  No distant metastasis\nM1  Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["63", "DISTAL BILE DUCT", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\n      mesenteric artery\nT4   Tumor involves the celiac axis, or the superior mesenteric artery\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nTis  Carcinoma in situ\nT1   Tumor confined to the bile duct histologically\nT2   Tumor invades beyond the wall of the bile duct\nT3   Tumor invades the gallbladder, pancreas, duodenum or other adjacent\n      organs without involvement of the celiac axis, or the superior\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0  No distant metastasis\nM1  Distant metastasis\n
\n
\n", "", "", "", "", "", ""], ["64", "CORPUS UTERI ADENOCARCINOMA", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT2a  Tumor involves adnexa\nT2b  Tumor involves other pelvic tissues\nT3   Tumor involves abdominal tissues\nT3a  One site\nT3b  More than one site\nT4   Tumor invades bladder or rectum\n \nTX   Primary tumor cannot be assessed\nT0   No evidence of primary tumor\nT1   Tumor limited to the uterus\nT1a  Tumor limited to the endometrium/endocervix\nT1b  Tumor invades to less than half of the myometrium\nT1c  Tumor invades more than half of the myometrium\nT2   Tumor extends beyond the uterus, within the pelvis\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No regional lymph node metastasis\nN1  Regional lymph node metastasis\n
\n
\n", "", "", "", "", "", "", "", "", ""], ["65", "ADRENAL", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["66", "OCULAR ADNEXAL LYMPHOMA", "", "", "", "", "", "", "", "
\n
\n\n
\n", "
\nPrimary Tumor (T)\nT2a  Anterior orbital involvement (+/- conjunctival involvement)\nT2b  Anterior orbital involvement (+/- conjunctival involvement + lacrimal\n      involvement)\nT2c  Posterior orbital involvement (+/- conjunctival involvement +/-\n      anterior involvement and +/- any extraocular muscle involvement)\nT2d  Nasolacrimal drainage system involvement (+/- conjunctival\n      involvement but not including nasopharynx)\nT3   Lymphoma with pre-septal eyelid involvement (defined above) +/-\n      orbital involvement +/- any conjunctival involvement\nT4   Orbital adnexal lymphoma extending beyond orbit to adjacent\n \n      structures such as bone and brain\nT4a  Involvement of nasopharynx\nT4b  Osseous involvement (including periosteum)\nT4c  Involvement of maxillofacial, ethmoidal and/or frontal sinuses\nT4d  Intracranial spread\nTX   Lymphoma extent not specified\nT0   No evidence of lymphoma\nT1   Lymphoma involving the conjunctiva alone without orbital involvement\nT1a  Bulbar conjunctiva only\nT1b  Palpebral conjunctiva +/- fornix +/- caruncle\nT1c  Extensive conjunctival involvement\nT2   Lymphoma with orbital involvement +/- any conjunctival involvement\n
\n
\n", "
\n
\n\n
\n", "
\nRegional Lymph Nodes (N)\n \nNX  Regional lymph nodes cannot be assessed\nN0  No evidence of lymph node involvement\nN1  Involvement of ipsilateral regional lymph nodes\nN2  Involvement of contra lateral or bilateral regional lymph nodes\nN3  Involvement of peripheral lymph nodes not draining ocular adnexal\n    region\nN4  Involvement of central lymph nodes\n
\n
\n", "", "
\n
\n\n
\n", "
\nDistant Metastasis (M)\n \nM0   No evidence of involvement of other extranodal sites\nM1a  Noncontiguous involvement of tissues or organs external to the ocular\n      adnexa (e.g., parotid glands, submandibular gland, lung, liver,\n      spleen, kidney, breast, etc.)\nM1b  Lymphomatous involvement of the bone marrow\nM1c  Both M1a and M1b involvement\n
\n
\n", "", "", "", "", "", ""], ["7", "MAJOR SALIVARY GLANDS", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["8", "THYROID GLAND", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["9", "ESOPHAGUS", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""]]}